Vanguard Mid-Cap Growth ETF

Most Recent

  • uploads///hog pm
    Company & Industry Overviews

    Stifel Downgrades Harley-Davidson to ‘Hold’

    Harley-Davidson fell by 0.91% to close at $48.10 per share on July 15. Its weekly, monthly, and YTD price movements are -1.3%, 9.0%, and 7.8%, respectively.

    By Gabriel Kane
  • uploads///bwa pm
    Company & Industry Overviews

    BorgWarner Saw a Steep 9.5% Fall

    BorgWarner (BWA) has a market cap of $7.6 billion. It fell by 9.5% to close at $33.84 per share on January 13, 2016.

    By Gabriel Kane
  • uploads///recommendation
    Company & Industry Overviews

    Discussing Analysts’ Latest Recommendations on VAR Stock

    Varian Medical Systems (VAR) is a better-aligned, leaner business with a strong market position after the spin-off of Varex Imaging (VREX) in January 2017.

    By Sarah Collins
  • uploads///kors pm
    Earnings Report

    Michael Kors’s Top Line and EPS Rose in 4Q16

    Michael Kors’s (KORS) cash and cash equivalents fell by 28.3%, and its inventories rose by 5.2% in fiscal 2016.

    By Gabriel Kane
  • uploads///
    Fund Managers

    Fairholme Lowers Its Stake in Leucadia National Corporation

    Due to its long-term value-oriented investment style and its interests in diversified businesses, Leucadia National is known as Baby Berkshire.

    By Santiago Solari
  • uploads///lulu pm
    Earnings Report

    Lululemon Athletica’s Revenue Rose, Income Fell in Fiscal 3Q15

    Lululemon Athletica reported net revenue of $479.7 million for fiscal 3Q15, a rise of 14.4% when compared to net revenue of $419.4 million in fiscal 3Q14.

    By Gabriel Kane
  • uploads///lulu pm
    Company & Industry Overviews

    Lululemon Raised Projections and Seres Made Deal with Nestle

    Lululemon Athletica (LULU) rose by 3.8% to close at $56.82 per share as of January 12, 2016.

    By Gabriel Kane
  • uploads///lulu pm
    Company & Industry Overviews

    Susquehanna Raises Price Target for Lululemon Athletica

    Lululemon Athletica is trading 4.9% above its 20-day moving average, 11.7% above its 50-day moving average, and 2.4% below its 200-day moving average.

    By Gabriel Kane
  • uploads///leading position
    Company & Industry Overviews

    Why Barrington Research Cut Its Target Price on Dentsply Sirona

    On March 27, 2018, Barrington Research reiterated its “buy” rating on Dentsply Sirona (XRAY) while reducing its target price on the stock from $70 to $69.

    By Sarah Collins
  • uploads///RECMMENDATIONS
    Company & Industry Overviews

    Wall Street Issues Majority ‘Buy’ Ratings on Align Technology

    On December 29, 2017, according to 12 investment brokerage firms which were part of a Reuters survey, Align Technology stock has received a “buy” rating from 11 analysts.

    By Sarah Collins
  • uploads///harpoon
    Company & Industry Overviews

    Edwards Lifesciences Expands Portfolio with Harpoon Medical Acquisition

    On December 6, 2017, Edwards Lifesciences (EW) announced the completion of its acquisition of Harpoon Medical for $100 million in cash on December 1, 2017.

    By Sarah Collins
  • uploads///analyst recommendations
    Company & Industry Overviews

    Varian’s Latest Wall Street Recommendations: Mostly ‘Hold’

    According to a recent Reuters survey, which included eight investment brokerage firms, six (or 75%) of them have recommended a “hold” for VAR stock.

    By Sarah Collins
  • uploads///Graph
    Company & Industry Overviews

    Edwards Lifesciences: Analyst Recommendations in November

    In 3Q17, Edwards Lifesciences (EW) reported adjusted sales of ~$838 million, which is an underlying growth of ~13% on a YoY basis. This performance was driven by double-digit organic growth.

    By Margaret Patrick
  • uploads///revenue estimates
    Earnings Report

    Edwards Lifesciences: Analysts Expect 12.5% 3Q17 Revenue Growth

    According to Wall Street analysts’ estimates for 3Q17, Edwards Lifesciences is expected to have revenues of $8.3 billion, a YoY (year-over-year) sales growth of 12.5%.

    By Sarah Collins
  • uploads///leading portfolio
    Company & Industry Overviews

    Developments in Dentsply Sirona’s Digital Dentistry Portfolio

    On September 20, 2017, Dentsply Sirona (XRAY) announced an enhancement to its Galileos Implant software.

    By Sarah Collins
  • uploads///Analysts ratings
    Company & Industry Overviews

    Jazz Pharmaceuticals on the Street: Analysts’ Recommendations after 1H17

    In July 2017, Jazz Pharmaceuticals entered into a license agreement with XL-Protein GmbH involving products using XL-Protein’s PASylation technology.

    By Daniel Collins
  • uploads///SAPIEN  DATA
    Company & Industry Overviews

    FDA Approvals Could Drive Edwards Lifesciences’ Growth

    On June 5, 2017, Edwards Lifesciences’ Sapien 3 valve was approved by the FDA for use in the aortic and mitral valve-in-valve procedure.

    By Sarah Collins
  • uploads///PROJECTIONS
    Company & Industry Overviews

    Discussing Dentsply Sirona’s Updated 2017 Guidance

    Dentsply Sirona made a downward revision to its fiscal 2017 guidance during the company’s 2Q17 earnings results announcement on August 9, 2017.

    By Sarah Collins
  • uploads///profitability drivers
    Company & Industry Overviews

    Why Varian Medical Systems’ Profitability Is Improving

    Varian Medical Systems’ profitability In 3Q17, Varian Medical Systems reported a gross margin of approximately 44.5%, representing an 18-basis-point improvement in the quarter. YTD (year-to-date), the margin has improved by around 138 basis points. In 3Q17, the company’s Oncology Systems business witnessed a gross margin improvement of 200 basis points to reach 48.1% of the segment’s total […]

    By Sarah Collins
  • uploads///Graph
    Company & Industry Overviews

    Edwards Lifesciences Focuses on Launch of SAPIEN 3 Ultra and CENTERA Valves

    Edwards Lifesciences’ (EW) SAPIEN 3 Ultra system is a next-generation platform, with expandable Axela sheath technology and on-balloon delivery design.

    By Margaret Patrick
  • uploads///Naglazyme Aldurazyme revenues
    Company & Industry Overviews

    BioMarin Expects These Drugs to Generate Steady Revenues

    In 2016, BioMarin Pharmaceuticals’ (BMRN) Naglazyme generated revenues of around $297 million, a ~2% year-over-year (or YoY) decline.

    By Daniel Collins
  • uploads///Under Armours Increasing Revenue With Increasing Market Share
    Company & Industry Overviews

    Baron: Under Armour Is Cheap Compared to the Last Couple of Years

    Under Armour is currently struggling to meet investors’ expectations, as it missed analysts’ estimates in 4Q16. It reported a 12% rise in revenue in the quarter, missing expectations.

    By Mary Sadler
  • uploads///kors pm
    Company & Industry Overviews

    Piper Jaffray Downgrades Michael Kors Holdings to ‘Neutral’

    On January 3, 2017, Piper Jaffray downgraded Michael Kors Holdings’s (KORS) rating from “overweight” to “neutral.” It also lowered the stock’s price target from $60.00 to $48.00 per share.

    By Gabriel Kane
  • uploads///kors pm
    Company & Industry Overviews

    Morgan Stanley Downgrades Michael Kors Holdings to ‘Equal-Weight’

    Michael Kors Holdings (KORS) has a market cap of $7.7 billion. It fell 5.1% to close at $47.16 per share on November 14, 2016.

    By Gabriel Kane
  • uploads///kors pm
    Earnings Report

    A Look at Michael Kors Holdings’s Fiscal 2Q17 Performance

    Michael Kors Holdings (KORS) has a market cap of $9.0 billion. It rose 3.2% to close at $51.76 per share on November 10, 2016.

    By Gabriel Kane
  • uploads///kors pm
    Company & Industry Overviews

    Guggenheim Has Given Michael Kors Holdings a ‘Neutral’ Rating

    Michael Kors Holdings (KORS) has a market cap of $7.9 billion. It fell 0.17% to close at $46.79 per share on September 30, 2016.

    By Gabriel Kane
  • uploads///kors pm
    Company & Industry Overviews

    CLSA Rates Michael Kors Holdings as a ‘Sell’

    Price movement Michael Kors Holdings (KORS) has a market cap of $7.9 billion. It fell 2.8% to close at $46.87 per share on September 29, 2016. The stock’s weekly, monthly, and year-to-date (or YTD) price movements were -6.5%, -4.8%, and 17.0%, respectively, on the same day. KORS is trading 3.9% below its 20-day moving average, […]

    By Gabriel Kane
  • uploads///Chart
    Company & Industry Overviews

    Incyte’s Profitability Improves, Allowing for Revised Guidance

    Incyte (INCY) reported revenues of $246.3 million in 2Q16, an increase of 51% compared to $163 million in 2Q15.

    By Mike Benson
  • uploads///kors pm
    Basic Materials

    A Look at Michael Kors Holdings’s Performance in 1Q17

    Michael Kors Holdings (KORS) has a market cap of $8.7 billion. It fell by 2.8% to close at $48.71 per share on August 10, 2016.

    By Gabriel Kane
  • uploads///bwa pm
    Company & Industry Overviews

    BorgWarner Declares Dividend of $0.13 Per Share

    BorgWarner (BWA) has a market cap of $7.4 billion. It rose by 2.0% to close at $33.94 per share on July 26, 2016.

    By Gabriel Kane
  • uploads///hog pm
    Company & Industry Overviews

    Why Are 430,000 Harley-Davidson Motorcycles Being Investigated?

    Harley-Davidson (HOG) has a market cap of $8.9 billion. Its stock rose by 1.9% to close at $48.73 per share on July 8, 2016.

    By Gabriel Kane
  • uploads///hog pm
    Company & Industry Overviews

    Why Did Harley-Davidson Rise ~20% on July 1?

    Harley-Davidson (HOG) has a market capitalization of $8.2 billion. It rose by 19.8% to close at $54.25 per share on July 1, 2016.

    By Gabriel Kane
  • uploads///kors pm
    Company & Industry Overviews

    Michael Kors Made Changes in Its Management

    Michael Kors Holdings (KORS) is trading 9.9% above its 20-day moving average, 2.2% above its 50-day moving average, and 8.5% above its 200-day moving average.

    By Gabriel Kane
  • uploads///har pm
    Company & Industry Overviews

    Harman International Completed the Acquisition of TowerSec

    Harman International Industries (HAR) has a market cap of $5.8 billion. It rose by 6.1%. It closed at $81.41 per share as of March 11, 2016.

    By Gabriel Kane
  • uploads///lulu pm
    Company & Industry Overviews

    Lululemon Startup Laid Off Staff to Focus on Branding

    Lululemon Athletica (LULU) reported fiscal 3Q15 net revenue of $479.7 million, a rise of 14.4% when compared to net revenue of $419.4 million in fiscal 3Q14.

    By Gabriel Kane
  • uploads///har pm
    Company & Industry Overviews

    Harman’s Partnership with InterDigital to Expand its Business

    Harman International Industries has entered into a partnership with InterDigital to deliver a suite of oneM2M- and 3GPP-compliant end-to-end Internet of Things (or IoT) solutions to the market.

    By Gabriel Kane
  • uploads///lulu pm
    Company & Industry Overviews

    Wells Fargo Upgraded Lululemon’s Rating to “Outperform”

    After Wells Fargo upgraded its stock from “market perform” to “outperform,” Lululemon Athletica rose by 6.5% to close at $55.86 per share as of January 4.

    By Gabriel Kane
  • uploads///lulu pe
    Earnings Report

    How Did Lululemon Athletica Compare to Its Peers?

    Lululemon Athletica (LULU) has mostly outperformed its peers, namely NIKE (NKE), The GAP Inc. (GPS), and Express Inc. (EXPR), based on PE, PBV, and PS.

    By Gabriel Kane
  • uploads///Kraft Heinz Companys Segment Performance Comparison
    Earnings Report

    Kraft Heinz’s US Segment Contributed 77% to Revenue

    Kraft Heinz (KHC) operates in four segments—the US, Canada, Europe, and the Rest of World. The US segment’s net sales were $4.5 billion—a fall of 3.7%.

    By Sushree Mohanty
  • uploads///Hain Celestials Operating and Net Earnings
    Earnings Report

    Hain Celestial’s Acquisitions in Fiscal 2015 and Their Benefits

    In the third quarter of fiscal 2015, the Hain Celestial Group acquired the remaining ~80% of EK Holdings and its wholly owned subsidiary, Empire Kosher Poultry.

    By Sushree Mohanty
  • uploads///Kellogg Companys Operating and Net Eanings
    Earnings Report

    Kellogg’s Acquisitions and Their Benefits

    The price of Kellogg’s acquisition of Diamond Foods is expected to reach over $1.5 billion, and Kellogg could offer the company between $35 and $40 per share.

    By Sushree Mohanty
  • uploads///VRSN
    Earnings Report

    VeriSign Adds 1.68 Million New Domain Names in 3Q15

    In 3Q15, VeriSign (VRSN) had cash, cash equivalents, and marketable securities of $1.9 billion, an increase of $466 million compared to year-end 2014.

    By Adam Rogers
  • uploads///ADSK
    Fund Managers

    Eminence Capital Lowers Position in Autodesk

    During the fourth quarter of 2014, Eminence Capital decreased its stake in Autodesk (ADSK). The company accounted for 2.62% of the fund’s 4Q14 portfolio.

    By Diana Key
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.